|
1
|
Sharma A, Sharma KL, Gupta A, Yadav A and Kumar A: Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update. World J Gastroenterol. 23:3978–3998. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Baiu I and Visser B: Gallbladder Cancer. JAMA. 320:12942018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hickman L and Contreras C: Gallbladder Cancer: Diagnosis, Surgical Management, and Adjuvant Therapies. Surg Clin North Am. 99:337–355. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yifan T, Zheyong L, Miaoqin C, Liang S and Xiujun C: A predictive model for survival of gallbladder adenocarcinoma. Surg Oncol. 27:365–372. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vega EA, Sanhueza M and Viñuela E: Minimally Invasive Surgery for Gallbladder Cancer. Surg Oncol Clin N Am. 28:243–253. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bhan A, Soleimani M and Mandal SS: Long Noncoding RNA and Cancer: A New Paradigm. Cancer Res. 77:3965–3981. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang Y and Tang L: The Application of lncRNAs in Cancer Treatment and Diagnosis. Recent Patents Anticancer Drug Discov. 13:292–301. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Castro-Oropeza R, Melendez-Zajgla J, Maldonado V and Vazquez-Santillan K: The emerging role of lncRNAs in the regulation of cancer stem cells. Cell Oncol (Dordr). 41:585–603. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang J, Liu H, Shen X, Wang Y, Zhang D, Shen S, Suo T, Pan H, Ming Y, Ding K, et al: Long non-coding RNA expression profiles in gallbladder carcinoma identified using microarray analysis. Oncol Lett. 13:3508–3516. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hu YP, Jin YP, Wu XS, Yang Y, Li YS, Li HF, Xiang SS, Song XL, Jiang L, Zhang YJ, et al: LncRNA-HGBC stabilized by HuR promotes gallbladder cancer progression by regulating miR-502-3p/SET/AKT axis. Mol Cancer. 18:1672019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ji D, Zhong X, Jiang X, Leng K, Xu Y, Li Z, Huang L, Li J and Cui Y: The role of long non-coding RNA AFAP1-AS1 in human malignant tumors. Pathol Res Pract. 214:1524–1531. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen J, Yu Y, Li H, Hu Q, Chen X, He Y, Xue C, Ren F, Ren Z, Li J, et al: Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer. Mol Cancer. 18:332019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liang C, Yang P, Han T, Wang RY, Xing XL, Si AF, Ma QY, Chen Z, Li HY and Zhang B: Long non-coding RNA DILC promotes the progression of gallbladder carcinoma. Gene. 694:102–110. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang L, Cheng X, Ge N, Guo W, Feng F and Wan F: Long non-coding RNA SPRY4-IT1 promotes gallbladder carcinoma progression. Oncotarget. 8:3104–3110. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang W, Su X, Yan W, Kong Z, Wang D, Huang Y, Zhai Q, Zhang X, Wu H, Li Y, et al: Overexpression of AR-regulated lncRNA TMPO-AS1 correlates with tumor progression and poor prognosis in prostate cancer. Prostate. 78:1248–1261. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo X and Wang Y: LncRNA TMPO-AS1 promotes hepatocellular carcinoma cell proliferation, migration and invasion through sponging miR-329-3p to stimulate FOXK1-mediated AKT/mTOR signaling pathway. Cancer Med. 9:5235–5246. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gang X, Yuan M and Zhang J: Long Non-Coding RNA TMPO-AS1 Promotes Cervical Cancer Cell Proliferation, Migration, and Invasion by Regulating miR-143-3p/ZEB1 Axis. Cancer Manag Res. 12:1587–1599. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Luo H, Yang L, Liu C, Wang X, Dong Q, Liu L and Wei Q: TMPO-AS1/miR-98-5p/EBF1 feedback loop contributes to the progression of bladder cancer. Int J Biochem Cell Biol. 122:1057022020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Edge SB and Compton CC: The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM. Ann Surg Oncol. 17:1471–1474. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hua CB, Song SB, Ma HL and Li XZ: MiR-1-5p is down-regulated in gallbladder carcinoma and suppresses cell proliferation, migration and invasion by targeting Notch2. Pathol Res Pract. 215:200–208. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nepal C, Zhu B, O'Rourke CJ, Bhatt DK, Lee D, Song L, Wang D, Van Dyke AL, Choo-Wosoba H, Liu Z, et al: Integrative molecular characterisation of gallbladder cancer reveals micro-environment-associated subtypes. J Hepatol. 74:1132–1144. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Khan MR and Begum S: Extended resection for xanthogranulomatous cholecystitis mimicking gallbladder carcinoma: Cases and review of diagnostic approach. J Pak Med Assoc. 69:256–260. 2019.PubMed/NCBI
|
|
23
|
Yadav S, DE Sarkar N, Kumari N, Krishnani N, Kumar A and Mittal B: Targeted Gene Sequencing of Gallbladder Carcinoma Identifies High-impact Somatic and Rare Germline Mutations. Cancer Genomics Proteomics. 14:495–506. 2017.PubMed/NCBI
|
|
24
|
Wang SH, Zhang WJ, Wu XC, Weng MZ, Zhang MD, Cai Q, Zhou D, Wang JD and Quan ZW: The lncRNA MALAT1 functions as a competing endogenous RNA to regulate MCL-1 expression by sponging miR-363-3p in gallbladder cancer. J Cell Mol Med. 20:2299–2308. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Peng WX, Koirala P and Mo YY: LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 36:5661–5667. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mitobe Y, Ikeda K, Suzuki T, Takagi K, Kawabata H, Horie-Inoue K and Inoue S: ESR1-Stabilizing Long Noncoding RNA TMPO-AS1 Promotes Hormone-Refractory Breast Cancer Progression. Mol Cell Biol. 39:e00261–e00269. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang J, Liang B and Hou S: TMPO-AS1 promotes cervical cancer progression by upregulating RAB14 via sponging miR-577. J Gene Med. 21:e31252019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Qin Z, Zheng X and Fang Y: Long noncoding RNA TMPO-AS1 promotes progression of non-small cell lung cancer through regulating its natural antisense transcript TMPO. Biochem Biophys Res Commun. 516:486–493. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mu X, Wu H, Liu J, Hu X, Wu H, Chen L, Liu W, Luo S and Zhao Y: Long noncoding RNA TMPO-AS1 promotes lung adenocarcinoma progression and is negatively regulated by miR-383-5p. Biomed Pharmacother. 125:1099892020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cui H and Zhao J: LncRNA TMPO-AS1 serves as a ceRNA to promote osteosarcoma tumorigenesis by regulating miR-199a-5p/WNT7B axis. J Cell Biochem. 121:2284–2293. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Peng X, Yan J and Cheng F: LncRNA TMPO-AS1 up-regulates the expression of HIF-1α and promotes the malignant phenotypes of retinoblastoma cells via sponging miR-199a-5p. Pathol Res Pract. 216:1528532020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mitobe Y, Ikeda K, Sato W, Kodama Y, Naito M, Gotoh N, Miyata K, Kataoka K, Sasaki H, Horie-Inoue K, et al: Proliferation-associated long noncoding RNA, TMPO-AS1, is a potential therapeutic target for triple-negative breast cancer. Cancer Sci. 111:2440–2450. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li Y and Qin C: MiR-1179 inhibits the proliferation of gastric cancer cells by targeting HMGB1. Hum Cell. 32:352–359. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li WJ, Xie XX, Bai J, Wang C, Zhao L and Jiang DQ: Increased expression of miR-1179 inhibits breast cancer cell metastasis by modulating Notch signaling pathway and correlates with favorable prognosis. Eur Rev Med Pharmacol Sci. 22:8374–8382. 2018.PubMed/NCBI
|
|
35
|
Lin C, Hu Z, Yuan G, Su H, Zeng Y, Guo Z, Zhong F, Jiang K and He S: MicroRNA-1179 inhibits the proliferation, migration and invasion of human pancreatic cancer cells by targeting E2F5. Chem Biol Interact. 291:65–71. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang ZH, Chen RB, Lu LP, Mao AP, Guo H, Wu YT and Shan ZX: MicroRNA-1179 regulates proliferation and chemosensitivity of human ovarian cancer cells by targeting the PTEN-mediated PI3K/AKT signaling pathway. Arch Med Sci. 16:907–914. 2019. View Article : Google Scholar
|
|
37
|
Wang S, Wang L, Wu C, Sun S and Pan JH: E2F2 directly regulates the STAT1 and PI3K/AKT/NF-κB pathways to exacerbate the inflammatory phenotype in rheumatoid arthritis synovial fibroblasts and mouse embryonic fibroblasts. Arthritis Res Ther. 20:2252018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Clijsters L, Hoencamp C, Calis JJA, Marzio A, Handgraaf SM, Cuitino MC, Rosenberg BR, Leone G and Pagano M: Cyclin F Controls Cell-Cycle Transcriptional Outputs by Directing the Degradation of the Three Activator E2Fs. Mol Cell. 74:1264–1277.e7. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Iglesias-Ara A, Zenarruzabeitia O, Buelta L, Merino J and Zubiaga AM: E2F1 and E2F2 prevent replicative stress and subsequent p53-dependent organ involution. Cell Death Differ. 22:1577–1589. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhou Q, Zhang F, He Z and Zuo MZ: E2F2/5/8 Serve as Potential Prognostic Biomarkers and Targets for Human Ovarian Cancer. Front Oncol. 9:1612019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yao H, Lu F and Shao Y: The E2F family as potential biomarkers and therapeutic targets in colon cancer. Peer J. 8:e85622020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang Y, Han D, Wei W, Cao W, Zhang R, Dong Q, Zhang J, Wang Y and Liu N: MiR-218 Inhibited Growth and Metabolism of Human Glioblastoma Cells by Directly Targeting E2F2. Cell Mol Neurobiol. 35:1165–1173. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li X, Zhang Z, Jiang H, Li Q, Wang R, Pan H, Niu Y, Liu F, Gu H, Fan X, et al: Circular RNA circPVT1 Promotes Proliferation and Invasion Through Sponging miR-125b and Activating E2F2 Signaling in Non-Small Cell Lung Cancer. Cell Physiol Biochem. 51:2324–2340. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yao Z, Chen Q, Ni Z, Zhou L, Wang Y, Yang Y and Huang H: Long Non-Coding RNA Differentiation Antagonizing Nonprotein Coding RNA (DANCR) Promotes Proliferation and Invasion of Pancreatic Cancer by Sponging miR-214-5p to Regulate E2F2 Expression. Med Sci Monit. 25:4544–4552. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Huang JW, Luo XY, Li ZH and Lang BP: LncRNA NNT-AS1 regulates the progression of lung cancer through the NNT-AS1/miR-3666/E2F2 axis. Eur Rev Med Pharmacol Sci. 24:238–248. 2020.PubMed/NCBI
|
